Roflumilast CAS 162401-32-3 162401-32-3
1) Provide costomers with "one-stop"packaging service,from research,development,production,export and so on.
2) We have our own R&D and production base,equipped with advanced production equipment and precision testing the Unitef States Pharmacopoeia(USP),the Britis Pharmacopoeia(EP) and other international advanced standards.All products are through the KOSGER,HALAL certification,the ISO quality management system certification and the HACCP certification.
3) More than 12 years of export experience.
4)Competitive price in China market.
Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor and is a novel drug for the treatment of COPD. It is used to treat symptoms of bronchitis-related cough and hypermuga in patients with severe COPD. Roflumilast is not planned for the treatment of patients with COPD who have primary emphysema.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View